Literature DB >> 22528868

MicroRNAs and lung cancers: from pathogenesis to clinical implications.

Ji Qi1, David Mu.   

Abstract

Lung cancer is the leading cause of cancer-related deaths in the US and worldwide. Better understanding of the disease is warranted for improvement in clinical management. Here we summarize the functions of small-RNA-based, posttranscriptional gene regulators, i.e. microRNAs, in the pathogenesis of lung cancers. We discuss the microRNAs that play oncogenic as well as tumor suppressive roles. We also touch on the value of microRNAs as markers for diagnosis, prognosis and the promising field of microRNA-based novel therapies for lung cancers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528868      PMCID: PMC3725603          DOI: 10.1007/s11684-012-0188-4

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  277 in total

1.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

2.  MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1.

Authors:  Ji Qi; Shawn J Rice; Anna C Salzberg; E Aaron Runkle; Jason Liao; Dani S Zander; David Mu
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

Review 3.  let-7 and miR-17-92: small-sized major players in lung cancer development.

Authors:  Hirotaka Osada; Takashi Takahashi
Journal:  Cancer Sci       Date:  2011-01       Impact factor: 6.716

4.  Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival.

Authors:  Tom Donnem; Kenneth Lonvik; Katrine Eklo; Thomas Berg; Sveinung W Sorbye; Khalid Al-Shibli; Samer Al-Saad; Sigve Andersen; Helge Stenvold; Roy M Bremnes; Lill-Tove Busund
Journal:  Cancer       Date:  2011-01-24       Impact factor: 6.860

Review 5.  The promise of TRAIL--potential and risks of a novel anticancer therapy.

Authors:  Ronald Koschny; Henning Walczak; Tom M Ganten
Journal:  J Mol Med (Berl)       Date:  2007-04-17       Impact factor: 4.599

Review 6.  Transcriptional control of lung morphogenesis.

Authors:  Yutaka Maeda; Vrushank Davé; Jeffrey A Whitsett
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

7.  The let-7 microRNA reduces tumor growth in mouse models of lung cancer.

Authors:  Aurora Esquela-Kerscher; Phong Trang; Jason F Wiggins; Lubna Patrawala; Angie Cheng; Lance Ford; Joanne B Weidhaas; David Brown; Andreas G Bader; Frank J Slack
Journal:  Cell Cycle       Date:  2008-03-03       Impact factor: 4.534

8.  Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Authors:  Stephen Kalscheuer; Xiaoxiao Zhang; Yan Zeng; Pramod Upadhyaya
Journal:  Carcinogenesis       Date:  2008-09-09       Impact factor: 4.944

9.  miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.

Authors:  Elena Gallardo; Alfons Navarro; Nuria Viñolas; Ramon M Marrades; Tania Diaz; Bernat Gel; Angels Quera; Eva Bandres; Jesus Garcia-Foncillas; Jose Ramirez; Mariano Monzo
Journal:  Carcinogenesis       Date:  2009-09-07       Impact factor: 4.944

10.  Coordinated regulation of ATF2 by miR-26b in γ-irradiated lung cancer cells.

Authors:  Himanshu Arora; Rehana Qureshi; Ae-Kyung Park; Woong-Yang Park
Journal:  PLoS One       Date:  2011-08-25       Impact factor: 3.240

View more
  24 in total

Review 1.  Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.

Authors:  Swaroop Revannasiddaiah; Priyanka Thakur; Bhaskar Bhardwaj; Sridhar Papaiah Susheela; Irappa Madabhavi
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  MicroRNA-33a mediates the regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid transcription factor 1 (TTF-1/NKX2-1).

Authors:  Shawn J Rice; Shao-Chiang Lai; Lauren W Wood; Kaitlin R Helsley; E Aaron Runkle; Monte M Winslow; David Mu
Journal:  J Biol Chem       Date:  2013-04-26       Impact factor: 5.157

3.  miR-132/212 cluster inhibits the growth of lung cancer xenografts in nude mice.

Authors:  Judong Luo; Cuicui Meng; Yiting Tang; Shuyu Zhang; Meizhen Wan; Yanzhi Bi; Xifa Zhou
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  Diagnostic value of circulating microRNAs for lung cancer: a meta-analysis.

Authors:  Yongchun Shen; Tao Wang; Ting Yang; Qianjing Hu; Chun Wan; Lei Chen; Fuqiang Wen
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-06

5.  MicroRNA-299-3p promotes the sensibility of lung cancer to doxorubicin through directly targeting ABCE1.

Authors:  Dawei Zheng; Yan Dai; Song Wang; Xiaoyu Xing
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression.

Authors:  Haijian Wu; Yan Liu; Xiao Ou Shu; Qiuyin Cai
Journal:  Carcinogenesis       Date:  2016-03-31       Impact factor: 4.944

Review 7.  The complexity of thyroid transcription factor 1 with both pro- and anti-oncogenic activities.

Authors:  David Mu
Journal:  J Biol Chem       Date:  2013-07-01       Impact factor: 5.157

8.  Regulation of ca(2+) signaling in pulmonary hypertension.

Authors:  Amy L Firth; Jun Yeon Won; Won Sun Park
Journal:  Korean J Physiol Pharmacol       Date:  2013-02-14       Impact factor: 2.016

9.  MicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistance of lung adenocarcinoma cells via regulating Bcl-2/Bax expression.

Authors:  Jia-Yuan Huang; Shi-Yun Cui; Yi-Tian Chen; Hai-Zhu Song; Gui-Chun Huang; Bing Feng; Ming Sun; Wei De; Rui Wang; Long-Bang Chen
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

10.  Characteristic patterns of microRNA expression in human bladder cancer.

Authors:  Anastasia A Zabolotneva; Alex Zhavoronkov; Andrew V Garazha; Sergey A Roumiantsev; Anton A Buzdin
Journal:  Front Genet       Date:  2013-01-04       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.